← Every company
BeOne Medicines AG Patents
What BeOne Medicines AG has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
BGNE on carbonthat →Filings on file
42
Granted
1
Still pending
41
Filed under
3 names
42 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| SUBSTITUTED 6-(PYRIMIDIN-4-YL)QUINOLINE COMPOUNDS AS CYCLIN DEPENDENT KINASE INHIBITORSC07D 405/14, A61P 35/00, A61K 31/506, A61K 31/5377, C07D 405/12, C07D 413/14Filed as BeOne Medicines I GmbH2026-04-07Jing Li | pending |
| 1-(1-Oxo-1,2-Dihydrophthalazin-6-yl)Cycloalkyl-1-Carboxamide Derivatives as MTA-Cooperative Inhibitors of PRMT5C07D 401/14, A61P 35/00, A61K 31/502, A61K 31/506, C07D 401/12, C07D 417/14, C07D 491/048Filed as BeOne Medicines I GmbH2026-03-24Sanjia Xu | pending |
| 4-((5-(3-(4-(PYRIDIN-2-YL)CYCLOPENTYL)-1H-PYRAZOL-3-YL)AMINO)-BENZENESULFONAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS CDK INHIBITORS FOR THE TREATMENT OF CANCERC07D 401/08, C07D 403/08, A61P 35/00, A61K 31/4155, A61K 31/4178, A61K 31/423, A61K 31/428, A61K 31/437, A61K 31/4439, A61K 31/501, A61K 31/5025, A61K 31/506, A61K 31/5415, A61K 31/635, C07D 409/14, C07D 413/08, C07D 413/14, C07D 417/12, C07D 417/14, C07D 471/04, C07D 498/04, C07D 513/04Filed as BeOne Medicines I GmbH2026-03-13Changxin Huo | pending |
| CIRCULAR RNA AND PREPARATION METHODS THEREOFC12N 15/10, C12N 15/113, A61K 31/7105, A61K 48/005, C12N 15/67, C12N 15/79, C12N 15/85, C12N2310/122, C12N2310/124, C12N2310/531, C12N2830/42, C12N2840/203, C12N2840/44Filed as BeOne Medicines I GmbH2026-03-06Jiao LIN | pending |
| 5- SUBSTITUTED FUSED BICYCLIC HETEROARYL DERIVATIVES CONTAINING ACRYLAMIDE, COMPOSITIONS THEREOF, AND USES THEREOFC07D 413/14, A61K 31/423, A61K 31/501, A61K 31/5377, A61K 31/5386, C07D 405/14, C07D 409/14, C07D 417/14, C07D 471/04, C07D 491/048, C07D 491/107, C07D 498/10Filed as BeOne Medicines I GmbH2026-02-26Qiuwen WANG | pending |
| BICYCLIC COMPOUNDS AS CDK INHIBITORSC07D 409/12, C07D 487/04, A61P 35/00, C07D 409/14Filed as BEONE MEDICINES I GMBH2026-02-13Changxin Huo | pending |
| TREATMENT OF LUNG CANCER WITH ANTI-PD-1 AND CHEMOTHERAPYA61K 31/4545, A61K 39/39541, C07K 16/2818, A61P 35/04, A61P 35/00, A61K 33/243, A61K 31/4709, A61K 31/555, A61K 31/7048, A61K 45/06, A61K 47/26, A61K2039/505, A61K2039/54, A61K2039/545, A61K2300/00, C07K2317/24, C07K2317/52, C07K2317/565Filed as BeOne Medicines I GmbH2026-02-13Yiyuan MA | pending |
| Pyrido[2,3-B][1,4]Oxazines or Tetrahydropyrido[2,3-B][1,4]Oxazepines as IAP AntagonistsC07D 498/04, A61P 35/00, A61K 31/5377, A61K 31/5383, C07D 498/08, C07D 519/00Filed as BeOne Medicines I GmbH2026-02-06Jing Li | pending |
| Bioactive Conjugates, Preparation Method and Use ThereofA61P 35/00, A61K 47/68035, A61K 47/6889, A61K 47/6849, A61P 29/00, C07D 471/04, C07D 487/04, C07D 487/10, C07D 519/00, C07K 16/2803Filed as BeOne Medicines I GmbH2026-02-05Charng-Sheng Tsai | pending |
| CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOFC07D 487/04, Y02P 20/55, A61P 37/00, A61P 37/02, A61P 35/02, A61P 37/08, A61P 29/00, A61P 35/04, A61P 35/00, A61K 31/519, C07B2200/05, C07B2200/07, C07B2200/13Filed as BeOne Medicines I GmbH2026-01-21Zhiwei WANG | pending |
| BIOACTIVE CONJUGATES, PREPARATION METHOD AND USE THEREOFA61K 47/6811, A61K 47/68031, A61K 47/6889, A61K 47/6807, A61K 47/6851, A61K 47/6883, A61K 47/6871, A61K 47/6849, A61P 35/00, A61K 47/68037, A61K 31/353, A61K 31/4745, A61K 31/5517, A61K 31/706, A61K 38/05, A61K 38/06, C07K 16/00, C07K2317/21, C07K2317/24Filed as BeOne Medicines I GmbH2025-12-23Charng-Sheng Tsai | pending |
| BIOACTIVE CONJUGATES, PREPARATION METHOD AND USE THEREOFA61K 47/68031, A61K 47/6889, A61K 47/6851, A61K 47/6883, A61K 47/6871, A61K 47/6849, A61P 35/00, C07K 16/2827, C07K 16/2851Filed as BeOne Medicines I GmbH2025-12-23Charng-Sheng Tsai | pending |
| BENZOFURAN DERIVATIVES AS SIK INHIBITORS AND THE USE THEREOFA61P 29/00, C07D 307/83, A61P 37/00, A61K 31/343, A61K 31/351, A61K 31/397, A61K 31/4025, A61K 31/403, A61K 31/4035, A61K 31/404, A61K 31/4155, A61K 31/4178, A61K 31/422, A61K 31/4245, A61K 31/438, A61K 31/443, A61K 31/4525, A61K 31/454, A61K 31/4709, A61K 31/4725, A61K 31/496, A61K 31/501, A61K 31/506, A61K 31/5377, A61K 31/538, A61K 31/553, C07D 307/80, C07D 405/04, C07D 405/12, C07D 405/14, C07D 407/12, C07D 413/12, C07D 413/14, C07D 471/10, C07D 491/048Filed as BEONE MEDICINES I GMBH2025-12-02Jing Li | pending |
| COMPOUNDS FOR THE DEGRADATION OF EGFR KINASEA61K 47/55, A61P 35/00, A61K 47/545, A61K 31/4545, A61K 31/496, A61K 31/498, C07D 498/22Filed as BeOne Medicines I GmbH2025-11-26Huaqing LIU | pending |
| Bridged Cyclic 5-Amino-6,8-Dihydro-1H-Furo[3,4-D]Pyrrolo[3,2-B]Pyridine-2-Carboxamide Compounds, Compositions Thereof, and Methods of Treatment TherewithC07D 491/147, C07D 519/00, A61P 35/00, A61K 31/439, A61K 31/4995Filed as BeOne Medicines I GmbH2025-11-12Sanjia Xu | pending |
| Isoquinolinone Derivatives and 4H-Quinolizinone Derivatives and Pharmaceutical Compositions Thereof for the Treatment of DiseaseA61P 35/00, C07D 217/24, A61P 37/00, A61P 29/00, A61K 31/4375, A61K 31/472, A61K 31/4725, A61K 31/496, A61K 31/5025, A61K 31/506, A61K 31/519, A61K 31/5377, A61K 31/675, C07B 59/002, C07D 217/26, C07D 401/04, C07D 401/06, C07D 401/10, C07D 401/12, C07D 401/14, C07D 405/04, C07D 405/10, C07D 405/12, C07D 405/14, C07D 409/12, C07D 409/14, C07D 413/14, C07D 417/04, C07D 471/04, C07D 487/04, C07D 491/056, C07D 491/107, C07D 495/04, C07D 513/04, C07F 9/62Filed as BeOne Medicines I GmbH2025-11-06Ling Qin | pending |
| Targeted Pyrrolobenzodiazapine ConjugatesA61K 47/68035, C07D 487/04, A61K 47/6889, A61K 47/55, A61K 47/6849, A61P 25/00, A61P 35/00, C07D 519/00Filed as BeOne Medicines I GmbH2025-10-08Charng-Sheng Tsai | pending |
| Macrocyclic Compounds as RAS InhibitorsC07D 513/22, A61P 35/00, A61K 31/504, A61K 31/5377, A61K 31/5383, A61K 31/5386, A61K 31/551, C07D 519/00Filed as BeOne Medicines I GmbH2025-09-18Jing Li | pending |
| Bioactive Conjugate, Preparation Method Therefor and Use ThereofA61K 47/6803, A61K 47/68037, A61K 47/6889, A61K 47/6867, A61K 47/6849, A61K 47/6855, A61P 35/00, A61K 47/68031, C07D 285/08, C07D 403/12, C07D 417/04, C07D 417/12, C07D 491/22Filed as BeOne Medicines I GmbH2025-09-18Charng-Sheng Tsai | pending |
| ANTI-B7H3 ANTIBODIES AND METHODS OF USEC07K 14/70532, C07K 16/2827, A61K2039/505, C07K2317/22, C07K2317/24, C07K2317/31, C07K2317/41, C07K2317/565, C07K2317/569, C07K2317/64, C07K2317/732, C07K2317/734, C07K2317/92Filed as BeOne Medicines I GmbH2025-09-16Liang QU | pending |
| MUC1 Antibodies and Methods of UseC07K 16/3092, C07K2317/24, C07K2317/33, C07K2317/34, C07K2317/565, C07K2317/567, C07K2317/622, C07K2317/77, C07K2317/92, C07K2317/94Filed as BeOne Medicines I GmbH2025-09-02Qi Liu | pending |
| CD16A Antibodies and Methods of UseC07K 16/283, C07K2317/22, C07K2317/24, C07K2317/31, C07K2317/33, C07K2317/565, C07K2317/569, C07K2317/92, C07K2317/94, C07K2319/00Filed as BeOne Medicines I GmbH2025-09-02Qiansheng Ren | pending |
| PREPARATION METHODS FOR A HIGHLY CONCENTRATED PD1 ANTIBODY SOLUTION BY APPLYING SINGLE-PASS TANGENTIAL FLOW FILTRATION (SPTFF)C07K 1/34, B01D 61/146, B01D2311/18, B01D2315/16, C07K 16/2818Filed as BeOne Medicines I GmbH2025-08-07Yu JI | pending |
| SELF-STABILIZING LINKER CONJUGATESA61K 47/6889, A61K 47/68037, A61K 47/6803, A61K 47/6849, A61K 47/68031, C07D 207/452, C07H 15/26Filed as BEONE MEDICINES I GMBH2025-08-06Charng-Sheng Tsai | pending |
| CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASESC07D 487/04, A61P 35/00, A61K 31/426, A61K 31/4365, A61K 31/519, C07D 495/04, C07D 513/04, C07D 519/00Filed as BEONE MEDICINES I GMBH2025-07-29Zhikun Ni | pending |
| Heterocyclic CompoundsC07D 471/04, A61P 35/00, A61K 31/4188, A61K 31/426, A61K 31/4355, A61K 31/436, A61K 31/522, C07D 473/28, C07D 487/04, C07D 491/048, C07D 491/052, C07D 491/056, C07D 495/04, C07D 497/04, C07D 513/04, C07D 519/00Filed as BeOne Medicines I GmbH2025-07-29Guoliang Zhang | pending |
| Anti-cMet and Anti-EGFR Multispecific Antibody Drug ConjugatesA61K 47/68037, C07K 16/2863, A61K 47/6889, A61K 47/6851, A61K 47/6849, A61K 47/6879, A61P 35/00, A61K 47/68031, A61K2039/505, C07K 16/30, C07K2317/31, C07K2317/33, C07K2317/41, C07K2317/565, C07K2317/622, C07K2317/73, C07K2317/732, C07K2317/75, C07K2317/76, C07K2317/77, C07K2317/92Filed as BeOne Medicines I GmbH2025-07-23CHARNG-SHENG TSAI | pending |
| CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASESC07D 471/04, C07D 487/04, A61P 35/00, A61K 31/496, A61K 31/498, A61K 31/502, A61K 31/5025, A61K 31/506, A61K 31/519, A61K 31/541, C07B 59/002, C07D 519/00Filed as BEONE MEDICINES I GMBH2025-07-23Zhikun Ni | pending |
| 5-Amino-1H-Pyrrolo[3,2-b]Pyridine-2-Carboxamide Derivatives as MTA-Cooperative Inhibitors of PRMT5C07D 471/04, A61P 35/00, A61K 31/437, A61K 31/444, A61K 31/4545, A61K 31/4709, A61K 31/501, A61K 31/502, A61K 31/506, A61K 31/517, C07D 519/00Filed as BeOne Medicines I GmbH2025-07-15Jing Li | pending |
| ANTI-B7H3 ANTIBODIES AND METHODS OF USEA61P 35/00, C07K 16/2827, A61K 47/6817, A61K 45/06, C07K2317/21, C07K2317/31, C07K2317/33, C07K2317/40, C07K2317/565, C07K2317/622, C07K2317/73, C07K2317/732, C07K2317/77, C07K2317/92Filed as BeOne Medicines I GmbH2025-06-26Xiaoyan TANG | pending |
| Ketal Protected Intermediate for Sonrotoclax and Preparation Method ThereofA61P 35/00, C07D 221/20, C07D 471/04, A61P 37/00, A61K 31/437, C07D 491/113, C07D 519/00Filed as BeOne Medicines I GmbH2025-06-26Zhengfeng Li | pending |
| Salts and Solid Forms of Sonrotoclax IntermediateA61P 35/00, C07D 471/04, A61K 31/437, C07B2200/13, C07C 55/07Filed as BeOne Medicines I GmbH2025-06-26Liwen Xu | pending |
| Intermediates of Sonrotoclax and the Method of Preparing the SameC07D 471/04, C07D 491/113, C07D 519/00, A61P 37/00, A61P 35/00, A61K 31/437, A61K 31/438Filed as BeOne Medicines I GmbH2025-06-26Kai Peng | pending |
| B7H3 ANTIBODY DRUG CONJUGATESA61K 47/6851, A61P 35/00, A61K 47/68037, A61K 45/06, A61K 47/6889, A61K 47/65, A61K 47/6849, A61K 31/337, A61K2039/505, A61K2300/00, C07D 491/22, C07K 9/003, C07K 16/2827, C07K2317/24, C07K2317/30, C07K2317/73, C07K2317/92, C07K2317/94Filed as BEONE MEDICINES I GMBH2025-06-20Charng-Sheng Tsai | pending |
| BICYCLIC COMPOUNDS AS CDK INHIBITORSC07D 409/12, C07D 417/12, A61P 35/00, A61K 31/4155, A61K 31/428, A61K 31/433, A61K 31/437, A61K 31/454, A61K 31/5377, A61K 31/5415, C07D 417/14, C07D 513/04Filed as BeOne Medicines I GmbH2025-03-12Changxin HUO | pending |
| DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USEA61K 47/55, C07D 413/14, A61K 47/545, A61P 35/00, A61K 31/506, A61K 31/513, C07D 417/14, C07D 471/10, C07D 487/10Filed as BeOne Medicines I GmbH2025-02-07Changxin HUO | 12521440 |
| DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USEA61K 47/55, C07D 413/14, A61K 47/545, A61P 35/00, A61K 31/506, A61K 31/513, C07D 417/14, C07D 471/10, C07D 487/10Filed as BeOne Medicines I GmbH2024-06-28Changxin HUO | pending |
| Antibody Drug ConjugatesA61K 47/6889, A61P 35/00, A61K 47/68031, A61K 47/6851, A61K 47/6803, A61K 47/6849, A61K 47/68037Filed as BeOne Medicines I GmbH2024-06-27Charng-Sheng Tsai | pending |
| Bcl-2 InhibitorsA61K 31/496, C07D 471/04, A61P 35/00, A61K 31/437, C07D 207/09, C07D 403/12, C07D 405/14, C07D 471/14, C07D 519/00Filed as BeOne Medicines I GmbH2024-06-17Yunhang Guo | pending |
| HETEROCYCLIC COMPOUNDSA61P 35/00, C07D 487/04, A61K 31/5025, C07D 519/00Filed as BeOne Medicines GmbH2024-06-04Guoliang Zhang | pending |
| Substituted 6-(Pyrimidin-4-yl)Quinoline Compounds as Cyclin Dependent Kinase InhibitorsC07D 405/14, C07D 413/14, A61P 35/00, A61K 31/506, A61K 31/5377, A61K 31/5386, A61K 31/553, C07D 409/14, C07D 451/14, C07D 471/10, C07D 491/048, C07D 491/107, C07D 493/08, C07D 498/08, C07D 498/18Filed as BeOne Medicines I GmbH2024-04-01Jing LI | pending |
| Pyrazolopyridinone CompoundsA61P 35/00, C07D 471/04, C07D 487/04, A61K 31/437, A61K 31/444, A61K 31/496, A61K 31/498, A61K 31/501, A61K 31/519, A61K 31/5517, C07D 519/00Filed as BeOne Medicines I GmbH2024-02-02Guoliang Zhang | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.